Article Details
Retrieved on: 2021-03-05 15:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
This came on the heels of similar failures from Alexion's anti-C5 MAb Ultomiris and Inflarx's C5a-targeting IFX-1. Complement forms part of the innate ...
Article found on: www.evaluate.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here